Atypical manifestation of neurofibromatosis type 2 in a boy [12]

Eye

Volumn 19, Issue 6, 2005, Pages 705-706

  Bosch, Martina M ^a   Mironov, A ^b   Killer, H E ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR SUPPRESSOR PROTEIN;

AMBLYOPIA; ANOREXIA; BULIMIA; CASE REPORT; CATARACT; COMPUTER ASSISTED TOMOGRAPHY; CONVERGENT STRABISMUS; EYE MOVEMENT; GENETIC ANALYSIS; HEADACHE; HISTOPATHOLOGY; HUMAN; LETTER; MALE; NEURECTOMY; NEURILEMOMA; NEUROFIBROMATOSIS; NONSENSE MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT REFERRAL; PSYCHOLOGIC TEST; SCHOOL CHILD; SOCIAL PROBLEM; STRABISMUS SURGERY; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION; VOMITING; WEIGHT REDUCTION;

EID: 21244486616     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6701603     Document Type: Letter

References (3)

1. Rouleau GA, Merel P, Lutchman M, Sanson M, Zucman J, Marineau C et al. Alteration in a new gene encoding a putative membrane-organizing protein causes neurofibromatosis type 2. Nature 1993; 363(6429): 515-521.
2. Baser ME, Friedman JM, Wallace AJ, Ramsden RT, Joe H, Evans DG. Evaluation of clinical diagnostic criteria for neurofibromatosis 2. Neurology 2002; 59(11): 1759-1765.
3. Evans DG, Birch JM, Ramsden RT. Paediatric presentation of type 2 neurofibromatosis. Arch Dis Child 1999; 81(6): 496-499.